Transparency in Anesthesiology Billing
Most anesthesiologists collect less than they are entitled to because the billing and collections process in America is fundamentally broken. It is also difficult for anesthesiologists to evaluate the performance of their billing company. Are they coding clean claims? Are they actually taking the time to go after everything that is owed? Download this how-to guide to determine if you are with the right billing company.
Sponsored by:
Fusion Anesthesia Solutions, LLC
Address: 225 S Executive Dr. Brookfield, WI 53005
Phone: 262-933-3730
Contact Name: Jake Buss
Email: jbuss@fusionhsllc.com
Website: http://www.fusionanesthesia.com
Transparency in Anesthesiology Billing
Evaluating the performance of a current or prospective billing company is nearly impossible for most anesthesiologists. The truth is, medical billing isn't rocket science, but it's not a commodity product either. As a result, most anesthesiologists collect less than they are entitled to receive for their services because the billing and collections process in America is fundamentally broken. And to make matters worse, very few billing companies have the commitment, or infrastructure in place, to correct this.
Too many anesthesiologists are being taken advantage of by both the impersonal behemoths of the industry and smaller "discount" billing companies. These companies bill the easy money and leave the rest- up to 5-15% of the collectible total-on the table. That's your money they aren't collecting.
Here's everything you need to know to evaluate your billing company and understand if you're missing a significant portion of your potential earnings.
Fill out the form to read it now!
Lurbinectedin and Atezolizumab Combo Improves Survival in Extensive-Stage Small-Cell Lung Cancer
June 20th 2025When small-cell lung cancer (SCLC) has spread to distant parts of the body, it’s classified as extensive-stage, which applies to nearly two-thirds of SCLC cases at the time of diagnosis.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Women Pay More and Get Less from Employer Health Plans
June 19th 2025In a report by JPMorgan Chase's Morgan Health, it was found that 37% of women with employer-sponsored insurance said meeting their deductibles is difficult, and 36% reported that their plans didn’t cover care they expected—or paid less than anticipated.
Read More
